Company news
ABVC BioPharma, Inc. news in 2020
ABVC BioPharma, Inc.'s news releases, calls and decks from 2020, newest first.
American BriVision Announces Completed Patient Enrollment in Clinical Trial at UCSF for Treatment of Adult ADHD
June 14, 2020
American BriVision Increases Size of Private Placement to Raise $2 Million
May 20, 2020
American BriVision Conducts Site Monitoring Visit for Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
April 5, 2020
American BriVision Announces Postponement of Proposed Public Offering
February 24, 2020